GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action
G Sanacora, A Saricicek - CNS & Neurological Disorders-Drug …, 2007 - ingentaconnect.com
Increasing evidence suggests that abnormalities in amino neurotransmission are associated
with the neurobiology of depression. Preclinical studies demonstrate that GABA modulating …
with the neurobiology of depression. Preclinical studies demonstrate that GABA modulating …
Quetiapine in a case with Parkinson disease and pathological gambling
L Sevincok, A Akoglu, A Akyol - Journal of clinical …, 2007 - journals.lww.com
To the Editors: Restless legs syndrome (RLS) is a neurological disorder characterized by
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
Clozapine-associated restless legs syndrome
HS Duggal, DN Mendhekar - Journal of clinical …, 2007 - journals.lww.com
Restless legs syndrome (RLS) is a neurological disorder characterized by irresistible
movements and dysesthetic sensations in the legs. Its prevalence in general population …
movements and dysesthetic sensations in the legs. Its prevalence in general population …
Duloxetine and hyponatremia: a report of 5 cases
S Krüger, M Lindstaedt - Journal of clinical psychopharmacology, 2007 - journals.lww.com
To the Editors: Restless legs syndrome (RLS) is a neurological disorder characterized by
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
Duloxetine-induced excessive disturbing and disabling yawning
C De Las Cuevas, EJ Sanz - Journal of clinical …, 2007 - journals.lww.com
To the Editors: Restless legs syndrome (RLS) is a neurological disorder characterized by
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
The Asp40 μ-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers
JM Mitchell, HL Fields, RL White… - Journal of clinical …, 2007 - journals.lww.com
To the Editors: Restless legs syndrome (RLS) is a neurological disorder characterized by
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
Venlafaxine discontinuation syndrome and suicidal ideation: a case series
TE Stone, C Swanson, MD Feldman - Journal of clinical …, 2007 - journals.lww.com
To the Editors: Restless legs syndrome (RLS) is a neurological disorder characterized by
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
Inhibition of selective noradrenergic reuptake as treatment of pathological laughter
M Møller, G Andersen - Journal of clinical psychopharmacology, 2007 - journals.lww.com
Pure pathological laughter (PL) is a rare condition occurring in a variety of distinct
neurological diseases, most often described after stroke and multiple sclerosis (MS). 1, 2 In …
neurological diseases, most often described after stroke and multiple sclerosis (MS). 1, 2 In …
A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder
To the Editors: Restless legs syndrome (RLS) is a neurological disorder characterized by
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
irresistible movements and dysesthetic sensations in the legs. Its prevalence in general …
Sex differences in antidepressant response in a Canadian primary-care sample
S Grigoriadis, JZ Konarski, SH Kennedy… - Journal of clinical …, 2007 - journals.lww.com
The issue of sex moderating the response to antidepressants has been suspected for many
years (see Table 1). More recently, a differential response rate to antidepressant medication …
years (see Table 1). More recently, a differential response rate to antidepressant medication …